Analyst Ratings for Optimer Pharmaceuticals (OPTR) [Buys]
OPTR Rating Summary
OPTR Price Target Summary
- Highest: $25.00 (ThinkEquity)
- Lowest: $10.00 (Citadel Securities)
- Average: $17.70
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$17.70 (+23.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/19/2012 | Leerink Swann | New Coverage | Outperform (N/A) |
25.00 (N/A) |
14.49 | 14.38 | -0.76% | Details |
| 7/12/2012 | Canaccord Genuity » Updated 8/1/2012 |
New Coverage | Buy (N/A) |
22.00 (N/A) |
15.03 | 14.38 | -4.32% | Details |
| 6/15/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
20.00 (N/A) |
15.37 | 14.38 | -6.44% | Details |
| 5/14/2012 | ThinkEquity | New Coverage | Buy (N/A) |
25.00 (N/A) |
15.04 | 14.38 | -4.39% | Details |
| 9/21/2011 | Brean Capital | New Coverage | Buy (N/A) |
20.00 (N/A) |
16.12 | 14.38 | -10.79% | Details |
